Searched for
AFFORDABLE CARDIAC STENTS
Govt mulls over new category for advanced coronary stents, price ceiling increase to attract manufacturersThe government is considering creating a separate category for advanced coronary stents and raising the price ceiling to attract stent make...- Operation buyout: KKR, TPG, and other PE firms eye purchase of India's largest cardiac stent maker SMTMorgan Stanley PE Asia and Samara Capital collectively own 49% of the company while Kotak Pre IPO Opportunities Fund holds 6%. The Kotadias...
- Pharma industry urges govt for stable drug pricing policyThe Organisation of Pharmaceutical Producers of India (OPPI) has called for a stable and predictable drug pricing policy, urging the govern...
- After price cap, local stent makers capture 60% of marketPrice regulation has also allowed better margins to Indian companies even as locally made, lower-priced products gain in the market, helpin...
- Sanitation coverage in India almost doubled: PM Narendra ModiPrime Minister Narendra Modi today said the sanitation coverage in the country has increased from 38 per cent to nearly 80 per cent.
- Price control on stents to continue: GovtIndustry asked to be prepared to meet demand for medical devices, even as the Centre is laying grounds for the launch of its mega healthcar...
- Surgical strike! Prices of drug eluting stents cutCoronary stents are wire mesh tubes inserted into coronary arteries to clear blockages and prevent heart attacks.
- Drug eluting stents expected to get cheaperThe maximum price that patients should pay for drug eluting, bioresorbable vascular and biodegradable coronary stents was reduced to Rs 27,...
- Angioplasty cost falls up to 18 per cent on stent price capAngioplasty cost at corporate hospital chains came down by 8-12% to ₹2.05 lakh-2.20 lakh from ₹2.10 lakh-2.20 lakh, the study showed.
- India regulator wants medical devices added to price control list, document showsNPPA Chairman Bhupendra Singh said the essential medicines list - comprised of more than 350 items, most of them drugs should include ballo...
- Focus shifts to expensive pacemakers, lenses, cathetersAfter the capping of cardiac stent prices, the Rajya Sabha petitions committee has turned its attention to overpricing of other medical dev...
- NPPA to penalise companies offering freebies on stent salesInstances have come to the notice of NPPA that few companies dealing with coronary stents have come up with freebies by announcing schemes.
- NPPA asks hospitals, stent makers to list prices on websitesThe instructions are being issued in public interest for compliance of ceiling prices by stent makers, distributors and hospitals, the NPPA...
- First India-made dissolvable stent gets ministry nodUnlike drug-eluting stents that are made of metal and stay in the arteries forever, Meril’s 100 micron-thick BVS ‘MeRes100’ is made of mate...
- 14 more medical devices may see price regulationThe National Pharmaceutical Pricing Authority (NPPA) has begun scrutiny of such devices, even asking makers to log in every detail about th...
- Hospitals not allowed to profit on stents anymore: GovtAccording to data from the drug pricing regulator, hospitals were found earning exorbitant margins on stents—over 650% in some cases.
- Today US FDA approved stent is available for Indians for Rs 30,000: Devi Shetty, Narayana HrudayalayaThis is the first cut of regulation givt has come up with but getting the feedback from the the patient lobby, govt will consider amending ...
- Bare-metal stents not inferior to costlier drug-eluting ones: Norwegian studyThe observation comes at a time when India has decided to clamp price controls on stents and the govt is engaged with stakeholders in a rag...
- Orthopedic implants may get up to 50 per cent cheaper over suggested price capsThe National Health Systems Resource Centre has suggested price caps in a report to drug pricing regulator National Pharmaceutical Pricing ...
- 'Tap global potential for health care products'President A P J Abdul Kalam asks Indian companies to tap the vast potential for health care products in the international market.
Load More
